Activation of Kupffer cells inhibits tumor growth in a murine model system

International Journal of Cancer

Volumn 99, Issue 5, 2002, Pages 713-720

  Chen, George G ^a,b   Lau, Wan Y ^a   Lai, Paul B S ^a   Chun, Ying S ^a   Chak, Ernest C W ^a   Leung, Billy C S ^a   Lam, Isa K Y ^a   Lee, Janet F Y ^a   Chui, Albert K K ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

Apoptosis; Bcl 2; Caspase 8; IFN ; Kupffer cells; Nitric oxide; TNF ; Tumor

Indexed keywords

CASPASE 8; DNA; GAMMA INTERFERON; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL ACTIVATION; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOBLOTTING; KUPFFER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CASPASE 8; CASPASE 9; CASPASES; DNA DAMAGE; GLIOMA; IMMUNOHISTOCHEMISTRY; INTERFERON TYPE II; KUPFFER CELLS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; NITRIC OXIDE; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036100555     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10412     Document Type: Article

References (37)

1. The origin and function of tumor-associated macrophages
2. Therapeutical effect of activated human macrophages on a human tumor line growing in nude mice
3. Evidence that metastasis is less common in cirrhotic than normal liver: A systematic review of post-mortem case-control studies
4. Absence of colorectal cancer metastasis to the cirrhotic liver
5. Experimental biliary fibrosis correlates with increased numbers of fat-storing and Kupffer cells and portal endotoxemia
6. Cell population kinetics of Kupffer cells during the onset of fibrosis in rat liver by chronic carbon tetrachloride administration
7. The effect of Kupffer cell stimulation or depression on the development of liver metastases in the rat
8. The role of Kupffer cells in the surveillance of tumor growth in the liver
9. Macrophage-directed tumour immunotherapy revisited: Past and future of an old doctor's dilemma
10. Therapy of cancer metastasis by activation of the inducible nitric oxide synthase
11. Macrophages and cancer
12. Apoptosis in tumor biology and therapy
13. Induction of Fas and Fas ligand expression on malignant cells by Kupffer cells, a potential pathway of anti-liver metastases
14. Isolation and primary culture of rat Kupffer cells
15. Recent advances in the isolation of liver cells
16. The heterogeneity of mononuclear phagocytes in lymphoid organs: Distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3
17. Dependence of fluorodeoxyuridine-induced cytotoxicity and megabase DNA fragment formation on S phase progression in HT29 cells
18. Macrophage content of spontaneous metastases at different stages of growth
19. Recruitment of exogenous macrophages into metastases at different stages of tumor growth
20. Macrophage infiltration and tumor progression
21. Antitumor potential of pleural cavity macrophages in lung cancer patients without malignant effusion
22. Plasma membrane receptors of the mononuclear phagocyte system
23. Endotoxin stimulates liver macrophages to release mediators that inhibit an early step in hepadna virus replication
24. Cellular responses to interferon-gamma
25. Therapy of cancer metastasis by activation of the inducible nitric oxide synthase
26. The multifaceted roles of nitric oxide in cancer
27. Nitric oxide-releasing agents enhance cytokine-induced tumor necrosis factor synthesis in human mononuclear cells
28. Erratic behavior of nitric oxide within the immune system: Illustrative review of conflicting data and their immunopharmacological aspects
29. Caspase structure, proteolytic substrates and function during apoptotic cell death
30. Inhibition of Bcl-2-dependent cell survival by a caspase inhibitor: A possible new pathway for Bcl-2 to regulate cell death
31. Crm-A, bcl-2 and NDGA inhibit CD95L-induced apoptosis of malignant glioma cells at the level of caspase 8 processing
32. U937 apoptotic cell death by nitric oxide: Bcl-2 downregulation and caspase activation
33. Nitric oxide-mediated apoptosis of K-1735 melanoma cells is associated with downregulation of Bcl-2
34. Bcl-2 protects cells from cytokine-induced nitric-oxide-dependent apoptosis
35. Bcl-2 prevents nitric oxide-mediated apoptosis and poly (ADP-ribose) polymerase cleavage
36. Apoptosis of colorectal adenocarcinoma (COLO 201) by tumour necrosis factor-alpha (TNF-a) or interferon-gamma (IFN-γ), resulting from down-modulation of Bcl-2 expression